BridgeBio Pharma (BBIO) Prepaid Assets: 2019-2025
Historic Prepaid Assets for BridgeBio Pharma (BBIO) over the last 7 years, with Sep 2025 value amounting to $52.4 million.
- BridgeBio Pharma's Prepaid Assets rose 36.56% to $52.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.4 million, marking a year-over-year increase of 36.56%. This contributed to the annual value of $34.9 million for FY2024, which is 43.46% up from last year.
- Per BridgeBio Pharma's latest filing, its Prepaid Assets stood at $52.4 million for Q3 2025, which was down 13.02% from $60.2 million recorded in Q2 2025.
- BridgeBio Pharma's 5-year Prepaid Assets high stood at $60.2 million for Q2 2025, and its period low was $20.5 million during Q2 2023.
- In the last 3 years, BridgeBio Pharma's Prepaid Assets had a median value of $28.4 million in 2024 and averaged $33.7 million.
- Its Prepaid Assets has fluctuated over the past 5 years, first crashed by 37.27% in 2023, then surged by 112.14% in 2025.
- Quarterly analysis of 5 years shows BridgeBio Pharma's Prepaid Assets stood at $32.3 million in 2021, then plummeted by 32.06% to $21.9 million in 2022, then increased by 10.87% to $24.3 million in 2023, then skyrocketed by 43.46% to $34.9 million in 2024, then soared by 36.56% to $52.4 million in 2025.
- Its Prepaid Assets stands at $52.4 million for Q3 2025, versus $60.2 million for Q2 2025 and $35.4 million for Q1 2025.